Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03104322
What this trial is testing

Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
patientMpower Ltd. 7
Not applicableLooking for participantsNCT07312305
What this trial is testing

Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisSmall Airways Disease
University of Milan 100
Not applicableStudy completedNCT04031690
What this trial is testing

Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary FibrosisPatient-caregiver Dyads
Centre Hospitalier Universitaire Dijon 151
Large-scale testing (Phase 3)Ended earlyNCT00981747
What this trial is testing

Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Fibrosis
Alicia Gerke 12
Testing effectiveness (Phase 2)Study completedNCT02688647
What this trial is testing

A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kadmon Corporation, LLC 76
Not applicableStudy completedNCT02630940
What this trial is testing

Exhaled Breath Condensate Biomarkers and Cough in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of East Anglia 52
Early research (Phase 1)Study completedNCT06588517
What this trial is testing

Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 12
Early research (Phase 1)Study completedNCT05513950
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).

Who this might be right for
Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici S.p.A. 52
Large-scale testing (Phase 3)Study completedNCT02802345
What this trial is testing

Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 274
Not applicableLooking for participantsNCT07332117
What this trial is testing

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 30
Early research (Phase 1)Study completedNCT01199887
What this trial is testing

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
ImmuneWorks 30
Not applicableUnknownNCT05318599
What this trial is testing

Deep Learning Diagnostic and Risk-stratification for IPF and COPD

Who this might be right for
Lung; Disease, Interstitial, With FibrosisPulmonary Disease, Chronic ObstructiveArtificial Intelligence
Pediatric Clinical Research Platform 160
Testing effectiveness (Phase 2)Ended earlyNCT02138825
What this trial is testing

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Who this might be right for
Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Bayer 147
Not applicableActive Not RecruitingNCT07580053
What this trial is testing

Hereditary Influences on Pulmonary Fibrosis Trajectories

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)Idiopathic Pulmonary Fibrosis (IPF)Telomere Disease+2 more
Istituto Clinico Humanitas 250
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT01262001
What this trial is testing

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 90
Large-scale testing (Phase 3)Looking for participantsNCT07671911
What this trial is testing

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

Who this might be right for
Idiopathic Pulmonary Fibrosis
Trevi Therapeutics 306
Large-scale testing (Phase 3)Ended earlyNCT00052039
What this trial is testing

A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

Who this might be right for
Lung DiseasePulmonary Fibrosis
InterMune
Not applicableLooking for participantsNCT00373841
What this trial is testing

Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Pittsburgh 500
Testing effectiveness (Phase 2)Looking for participantsNCT07121413
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis(IPF)
Shanghai Synvida Biotechnology Co.,Ltd. 48
Next Page